ANNEX IV, Regulation (EU) 2016/161

In forcesince 2 Oct 2015

Note: The number of entries is not binding.

Notification to the European Commission of medicinal products judged not to be at risk of falsification, pursuant to article 54a(4) of Directive 2001/83/EC

Member State: | Name of competent authority:

Entry No | Active substance (Common Name) | Pharmaceutical form | Strength | Anatomical Therapeutical Chemical (ATC) Code | Comments/Complementary information

1 | | | | |

2 | | | | |

3 | | | | |

4 | | | | |

5 | | | | |

6 | | | | |

7 | | | | |

8 | | | | |

9 | | | | |

10 | | | | |

11 | | | | |

12 | | | | |

13 | | | | |

14 | | | | |

15 | | | | |